ES2259262B1 - COSMETIC PRODUCT. - Google Patents
COSMETIC PRODUCT. Download PDFInfo
- Publication number
- ES2259262B1 ES2259262B1 ES200402558A ES200402558A ES2259262B1 ES 2259262 B1 ES2259262 B1 ES 2259262B1 ES 200402558 A ES200402558 A ES 200402558A ES 200402558 A ES200402558 A ES 200402558A ES 2259262 B1 ES2259262 B1 ES 2259262B1
- Authority
- ES
- Spain
- Prior art keywords
- compound
- total
- cosmetic product
- glycol
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 102000008186 Collagen Human genes 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 15
- 229920001436 collagen Polymers 0.000 claims abstract description 15
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims abstract description 6
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000020279 black tea Nutrition 0.000 claims abstract description 6
- 239000004202 carbamide Substances 0.000 claims abstract description 6
- 235000009508 confectionery Nutrition 0.000 claims abstract description 6
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 6
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims abstract description 5
- 239000012190 activator Substances 0.000 claims abstract description 4
- 235000013311 vegetables Nutrition 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 44
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- -1 pentaerythritol ethers Chemical class 0.000 claims description 9
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 7
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 229940067596 butylparaben Drugs 0.000 claims description 4
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 4
- 229960003415 propylparaben Drugs 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 claims description 3
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 229940086555 cyclomethicone Drugs 0.000 claims description 3
- 229940008099 dimethicone Drugs 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229940031674 laureth-7 Drugs 0.000 claims description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960002216 methylparaben Drugs 0.000 claims description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 229940068977 polysorbate 20 Drugs 0.000 claims description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 6
- 230000037303 wrinkles Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 230000001815 facial effect Effects 0.000 description 5
- 239000008278 cosmetic cream Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000002199 base oil Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 241001631457 Cannula Species 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Producto cosmético compuesto por dos composiciones distintas. La primera composición es básicamente una base oleosa que contiene esferas deshidratadas de origen marino y vegetal, junto con otros ingredientes. La segunda de las composiciones es un gel activador con base acuosa que contiene básicamente ácido hialurónico, colágeno soluble, urea, té negro dulce fermentado y palmitoil pentapéptido-3 junto con otros ingredientes.Cosmetic product composed of two different compositions. The first composition is basically an oily base that contains dehydrated spheres of marine and vegetable origin, along with other ingredients. The second of the compositions is an aqueous-based activator gel that basically contains hyaluronic acid, soluble collagen, urea, fermented sweet black tea and palmitoyl pentapeptide-3 together with other ingredients.
Description
Producto cosmético.Cosmetic product.
El objeto de la presente patente de invención es presentar un nuevo producto cosmético para el relleno de arrugas de una forma no invasiva, de fácil aplicación, seguro, indoloro y de efecto inmediato.The object of the present invention patent is introduce a new cosmetic product for wrinkle filling a non-invasive, easy to apply, safe, painless and immediate effect
Hasta el momento, se relatan en el actual estado de la técnica diversos sistemas que intentan, de un modo u otro, eliminar las arrugas faciales. Estos sistemas los podemos encuadrar dentro de cuatro grandes grupos: los implantes faciales permanente o semipermanentes, las cremas cosméticas con ingredientes que favorecen la síntesis de colágeno o estimulan los fibroblastos, las cremas cosméticas con ingredientes que suavizan y estiran la piel, o los lipofilling faciales.So far, they are reported in the current state of the technique various systems that try, in one way or another, Eliminate facial wrinkles. We can frame these systems within four large groups: permanent facial implants or semi-permanent, cosmetic creams with ingredients that favor the synthesis of collagen or stimulate fibroblasts, the cosmetic creams with ingredients that soften and stretch the skin, or facial lipofilling.
Los implantes faciales permanentes o semipermanentes, destinados al relleno de surcos, arrugas y pliegues, así como al aumento del volumen de los labios, tienen una serie de inconvenientes, siendo el principal de todos el carácter de técnica invasiva (quirúrgica), con una evidente carga de dolor, así como la posibilidad de generar una serie de efectos secundarios no deseados, como son las reacciones alérgicas, la aparición de bultos o granulomas, trastornos físicos, reabsorción a corto plazo del implante y otros problemas derivados de una incorrecta aplicación.Permanent facial implants or semi-permanent, intended for filling grooves, wrinkles and folds, as well as increasing the volume of the lips, have a series of inconveniences, being the main one of all the character of invasive (surgical) technique, with an obvious pain load, as well as the possibility of generating a series of side effects unwanted, such as allergic reactions, the appearance of lumps or granulomas, physical disorders, short-term resorption of the implant and other problems derived from an incorrect application.
Las cremas cosméticas con ingredientes que favorecen la síntesis de colágeno, o estimulan los fibroblastos para que sinteticen moléculas de tejido conectivo (colágeno, fibronectina, glicosaminoglicanos) garantizan un alisamiento de la arruga a largo plazo, tras varios meses de tratamiento. Este sistema tiene como principal inconveniente su extremada dilatación en el tiempo, que el producto cosmético objeto de la presente patente de invención no tiene.Cosmetic creams with ingredients that favor the synthesis of collagen, or stimulate fibroblasts to synthesize connective tissue molecules (collagen, fibronectin, glycosaminoglycans) guarantee a smoothing of the Wrinkle in the long term, after several months of treatment. This system Its main drawback is its extreme dilation in the time, that the cosmetic product object of the present patent of invention has not.
Las cremas cosméticas con ingredientes que suavizan y estiran la piel provocando un efecto flash que de forma visible parecen reducir las arrugas, no rellenan en ningún caso la arruga. Al estirar la piel, disimulan los surcos durante un tiempo limitado (efecto instantáneo pero pasajero). Aparte de esto, este tipo de productos proporcionan una hidratación en las capas superficiales de la epidermis. El producto cosmético objeto de la presente patente de invención, además de hidratar las capas superficiales y medias de la epidermis, suaviza la superficie de la piel de forma inmediata.Cosmetic creams with ingredients that soften and stretch the skin causing a flash effect that visible appear to reduce wrinkles, do not fill in any case the wrinkle. When stretching the skin, they hide the grooves for a while limited (instant but temporary effect). Apart from this, this type of products provide a hydration in the layers superficial epidermis. The cosmetic product object of the present invention patent, in addition to moisturizing the layers superficial and middle of the epidermis, softens the surface of the skin immediately.
Por último el lipofilling facial consiste, a groso modo, en el relleno de la arruga con adipositos (grasa) del propio paciente. Este tratamiento resulta algo doloroso debido a que la inserción del relleno se realiza a través de unas cánulas.Finally, facial lipofilling consists of roughly, in the filling of the wrinkle with fat (fat) own patient This treatment is somewhat painful due to that the insertion of the filling is done through some cannulas
Para paliar o en su caso eliminar todos los inconvenientes arriba mencionados, se presenta este producto cosmético, objeto de la presente patente de invención.To alleviate or, where appropriate, eliminate all Disadvantages mentioned above, this product is presented cosmetic, object of the present invention patent.
Este producto cosmético está, a su vez, compuesto por dos composiciones distintas que serán aplicadas secuencialmente sobre el paciente.This cosmetic product is, in turn, composed of two different compositions that will be applied sequentially about the patient.
La primera de las composiciones es una base oleosa que contiene esferas deshidratadas de origen marino (colágeno y condroitín sulfato) y vegetal (proteínas de germen de trigo).The first of the compositions is a base oil containing dehydrated spheres of marine origin (collagen and chondroitin sulfate) and vegetable (germ proteins of wheat).
Estas esferas tienen un tamaño pequeño (de menos de 100 \mum) que permite que se depositen las esferas en las capas superiores de la epidermis.These spheres have a small size (less 100 µm) which allows the spheres to deposit in the upper layers of the epidermis.
Las esferas poseen propiedades hidrofílicas, son capaces de captar y retener grandes cantidades de agua en su interior. Por ello la necesidad de que se presenten en una base oleosa, en la que permanecen deshidratadas durante todo el tiempo.The spheres have hydrophilic properties, they are capable of capturing and retaining large amounts of water in their inside. Therefore the need for them to be presented on a base oil, in which they remain dehydrated throughout the weather.
Por otro lado, la segunda de las composiciones es un gel activador con base acuosa que contiene ácido hialurónico, colágeno soluble, urea, té negro dulce fermentado y palmitoil pentapéptido-3.On the other hand, the second of the compositions it is an aqueous-based activating gel that contains hyaluronic acid, soluble collagen, urea, fermented sweet black tea and palmitoil pentapeptide-3.
El ácido hialurónico y la urea son dos componentes naturales del organismo con propiedades hidratantes ampliamente documentadas en cosmetología.Hyaluronic acid and urea are two natural components of the body with moisturizing properties widely documented in cosmetology.
El té negro dulce fermentado posee un efecto anti-glicación, un efecto redensificador en la población de adipocitos y mejora la calidad de la piel (suavidad, luminosidad).Fermented sweet black tea has an effect anti-glycation, a redensifying effect on the adipocyte population and improves skin quality (softness, brightness).
El palmitoil pentapéptido-3 (PAL-KTTKS) estimula a los fibroblastos para que sinteticen moléculas del tejido conectivo, en concreto colágeno, fibronectina y glicosaminoglicanos, regenerando de esta forma la matriz dérmica, reduciendo las manchas cutáneas vinculadas al envejecimiento, mejorando la firmeza de la piel y disminuyendo las arrugas (actividad antiarrugas superior a la de la vitamina C). El colágeno soluble favorece la síntesis de colágeno.Palmitoyl Pentapeptide-3 (PAL-KTTKS) stimulates fibroblasts so that synthesize connective tissue molecules, specifically collagen, fibronectin and glycosaminoglycans, thus regenerating the dermal matrix, reducing skin spots linked to aging, improving skin firmness and reducing wrinkles (anti-wrinkle activity superior to that of vitamin C). He Soluble collagen favors the synthesis of collagen.
El mecanismo de acción de ambos compuestos es el siguiente:The mechanism of action of both compounds is the next:
En primer lugar, con la piel limpia y seca se aplica la primera de las composiciones. Pasados entre 10 y 15 minutos, tiempo en el que las esferas se han depositado sobre la piel, se aplica la segunda de las composiciones.First of all, with clean and dry skin it Apply the first of the compositions. Past 10-15 minutes, time in which the spheres have been deposited on the skin, the second of the compositions is applied.
Al poner en contacto ambos compuestos, las esferas que permanecían deshidratadas se rehidratan progresivamente al captar los activos hidratantes presentes en el gel activador (segunda composición).By contacting both compounds, the spheres that remained dehydrated progressively rehydrated when capturing the moisturizing assets present in the activator gel (second composition).
Este efecto de rehidratación hace que la esfera se "hinche" rellenando el surco de la arruga, suavizando las imperfecciones presentes en la superficie de la piel y proporcionado un efecto de lifting inmediato.This rehydration effect makes the sphere it "swells" by filling in the furrow of the wrinkle, softening the imperfections present on the surface of the skin and provided an immediate lifting effect.
En unos niveles de la piel más profundos, el resto de componentes presentes en el gel activador (segunda composición) ejercen un efecto redensificador, regenerador y anti-arrugas.At deeper skin levels, the other components present in the activator gel (second composition) exert a redensifying, regenerating and anti-wrinkle
El producto cosmético así descrito, y objeto de la presente patente de invención puede ser aplicado tanto localmente sobre la propia arruga o surco, como globalmente sobre toda la faz.The cosmetic product thus described, and object of The present invention patent can be applied both locally on the wrinkle itself or groove, as globally on The whole face
El producto cosmético objeto de la presente patente de invención está compuesto básicamente por dos componentes bien diferenciados. El primero de estos componentes, a su vez, está compuesto por ciclometicona, ciclopentaxilosano y PEG/PPG-19/19 dimeticona.The cosmetic product object of the present invention patent is basically composed of two components well differentiated. The first of these components, in turn, is composed of cyclomethicone, cyclopentaxylosan and PEG / PPG-19/19 dimethicone.
En una primera fase de fabricación estos productos se mezclarán entre si agitándose. Posteriormente se añadirán los siguientes componentes sucesivamente, agitándolos igualmente:In a first phase of manufacturing these products will mix with each other while stirring. Subsequently they will add the following components successively, shaking them equally:
- --
- Dimetil Sililato: Entre un 0,5 y un 5%, sobre el primer compuesto del producto cosmético.Dimethyl Silylate: Between 0.5 and 5%, on the first compound of the cosmetic product.
- --
- Proteína de trigo hidrolizada: Entre un 0,5 y un 5%, sobre el primer compuesto del producto cosmético.Hydrolyzed Wheat Protein: Enter a 0.5 and 5%, on the first product compound cosmetic.
- --
- Condroitín sulfato: Entre un 0,5 y un 5%, sobre el primer compuesto del producto cosmético.Chondroitin Sulfate: Between 0.5 and one 5%, on the first compound of the cosmetic product.
- --
- Colágeno: Entre un 0,5 y un 5%, sobre el primer compuesto del producto cosmético.Collagen: Between 0.5 and 5%, on the First compound of the cosmetic product.
- --
- Agua: Entre un 0,5 y un 3%, sobre el primer compuesto del producto cosmético.Water: Between 0.5 and 3%, on the first product compound cosmetic.
- --
- Pentaeritritil Tetraisosterato: Entre un 0,5 y un 5%, sobre el primer compuesto del producto cosmético.Pentaerythrityl Tetraisosterate: Enter a 0.5 and 5%, on the first product compound cosmetic.
- --
- Glicol Butileno: Entre un 0,5 y un 5%, sobre el primer compuesto del producto cosmético.Glycol Butylene: Between 0.5 and 5%, on the first compound of cosmetic product
- --
- Fenoxietanol: Entre un 0,001 y un 1%, sobre el primer compuesto del producto cosmético.Phenoxyethanol: Between 0.001 and 1%, on the first compound of the cosmetic product.
- --
- Propilparabeno: Entre un 0,001 y un 1%, sobre el primer compuesto del producto cosmético.Propylparaben: Between 0.001 and 1%, on the first compound of the cosmetic product.
- --
- Metiparabeno: Entre un 0,001 y un 1%, sobre el primer compuesto del producto cosmético.Metiparaben: Between 0.001 and 1%, on the first compound of the cosmetic product.
- --
- Butilparabeno: Entre un 0,001 y un 1%, sobre el primer compuesto del producto cosmético.Butyl Paraben: Between 0.001 and 1%, on the first compound of the cosmetic product.
- --
- Etilparabeno: Entre un 0,001 y un 1%, sobre el primer compuesto del producto cosmético.Ethylparaben: Between 0.001 and 1%, on the first compound of the cosmetic product.
Por otro lado, el segundo compuesto del producto cosmético está formado por agua, glicerina, pentileno glicol, butileno glicol, propileno glicol, carbomer (polímero de ácido acrílico entrecruzado con alil éteres de pentaeritritol y alil éteres de sucrosa), hidroxietilcelulosa, etilenodinitrilo (EDTA disódico) y trietanolamina, los cuales se dispersarán entre si, agitándose.On the other hand, the second compound of the cosmetic product is formed by water, glycerin, pentylene glycol, butylene glycol, propylene glycol, carbomer (acrylic acid polymer crosslinked with allyl ethers of pentaerythritol and allyl ethers of sucrose), hydroxyethylcellulose, ethylenedinitrile (EDTA disodium) and triethanolamine, which will disperse with each other, stirring.
Posteriormente se añaden sucesivamente los siguientes compuestos químicos, agitándose junto con los anteriores: isostearil isosterato, ciclopentaxilosano, dimeticonol, poliacrilamida, C13-C14 isoparafina y laureth-7 (polietileno glicol (7) lauril éter).Subsequently, successively added following chemical compounds, stirring together with the Previous: isostearyl isosterate, cyclopentaxylosan, dimethiconol, polyacrylamide, C13-C14 isoparaffin and Laureth-7 (polyethylene glycol (7) lauryl ether).
Finalmente, se disuelven entre sí los siguientes compuestos: Urea (entre el 0,5 y el 5% del total del segundo compuesto), té negro dulce fermentado (entre el 0,1 y el 10% del total del segundo compuesto), extracto de centella asiática (entre el 0,001 y el 1% del total del segundo compuesto), ácido hialurónico (entre el 0,005 y el 1% del total del segundo compuesto), colágeno soluble (entre el 0,0015 y el 0,001% del total del segundo compuesto), palmitoil pentapéptido-3 (entre el 0,00001 y el 0,001% del total del segundo compuesto), o-cimen-5-ol, polisorbato 20, fenoxietanol, metilparabeno, etilparabeno, butilparabeno, propilparabeno, y fragancia (perfume).Finally, the following dissolve Compounds: Urea (between 0.5 and 5% of the second total compound), fermented sweet black tea (between 0.1 and 10% of total of the second compound), extract of centella asiatica (between 0.001 and 1% of the total of the second compound), hyaluronic acid (between 0.005 and 1% of the total of the second compound), collagen soluble (between 0.0015 and 0.001% of the second total compound), palmitoyl pentapeptide-3 (between 0.00001 and 0.001% of the total of the second compound), o-cimen-5-ol, polysorbate 20, phenoxyethanol, methylparaben, ethylparaben, butylparaben, propylparaben, and fragrance (perfume).
Estos compuestos se añaden posteriormente a la mezcla de los componentes ya mencionados del segundo compuesto del producto cosmético, objeto de la presente patente de invención.These compounds are subsequently added to the mixing of the aforementioned components of the second compound of the cosmetic product, object of the present invention patent.
Una vez descrita suficientemente la naturaleza de la presente invención, así como una forma de llevarla a la práctica, solamente queda por añadir que dicha invención puede sufrir ciertas variaciones en forma y materiales, siempre y cuando dichas alteraciones no varíen sustancialmente las características que se reivindican a continuación.Once nature is sufficiently described of the present invention, as well as a way of bringing it to the practice, it only remains to be added that said invention can suffer certain variations in form and materials, as long as these alterations do not substantially vary the characteristics which are claimed below.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200402558A ES2259262B1 (en) | 2005-03-04 | 2005-03-04 | COSMETIC PRODUCT. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200402558A ES2259262B1 (en) | 2005-03-04 | 2005-03-04 | COSMETIC PRODUCT. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2259262A1 ES2259262A1 (en) | 2006-09-16 |
| ES2259262B1 true ES2259262B1 (en) | 2007-10-01 |
Family
ID=36998083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200402558A Active ES2259262B1 (en) | 2005-03-04 | 2005-03-04 | COSMETIC PRODUCT. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2259262B1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01207220A (en) * | 1988-02-10 | 1989-08-21 | Lion Corp | Composition for skin |
| JP2000191499A (en) * | 1998-12-25 | 2000-07-11 | Henkel Japan Ltd | Cosmetic for moisturiztng skin |
| JP2001039852A (en) * | 1999-07-29 | 2001-02-13 | Nonogawa Shoji Kk | External skin preparation |
| JP2003183129A (en) * | 2001-12-20 | 2003-07-03 | Nonogawa Shoji Kk | Makeup cosmetic |
| JP2004189694A (en) * | 2002-12-13 | 2004-07-08 | Seiwa Kasei:Kk | Face lotion |
-
2005
- 2005-03-04 ES ES200402558A patent/ES2259262B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2259262A1 (en) | 2006-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bukhari et al. | Hyaluronic acid, a promising skin rejuvenating biomedicine: A review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects | |
| ES2549534T3 (en) | Use of a natural agent in cosmetic compositions | |
| ES2568889T3 (en) | Association of monosaccharides with antioxidant agents and their use in cosmetics | |
| CN105664223B (en) | Cosmetic preparation, skin preparations for extenal use and medical instrument | |
| WO2014044808A2 (en) | Fast-penetration cosmetic dermal filler for topical application | |
| ES2655736T3 (en) | Association of monosaccharides with ascorbic acid and its use in cosmetics | |
| JP2023552126A (en) | Efficacy promoting composition and its use | |
| JP2009035497A (en) | Infiltration-promoting agent | |
| CN105709267B (en) | A kind of human-like collagen cell migration gel | |
| CN107496316A (en) | A kind of face cream and preparation method thereof | |
| ES2297279T3 (en) | COMPOSITION FOR SKIN CARE UNDERSTANDING A SKIN CLEARING AGENT. | |
| ES2689127T3 (en) | Compositions that have a plurality of discrete emulsions | |
| JP2016108344A (en) | Cosmetic containing small molecular weight of cationized hyaluronic acid | |
| CN108379215A (en) | A kind of cosmetic composition for having effects that the freeze-drying compound powder of skin whitening and including the freeze-drying compound powder | |
| JP5743406B2 (en) | Cosmetic or dermatological composition containing a retinoid, an adenosine-based non-phosphated compound and a semi-crystalline polymer | |
| ES2351381T3 (en) | COSMETIC COMPOSITION THAT INCLUDES AN ASCORBIC ACID COMPOUND OR A SALICYLIC ACID COMPOUND. | |
| ES2700951T3 (en) | Brightness compositions and methods of use | |
| Morganti | Chitin Nanofibrils in skin treatment | |
| KR20070118719A (en) | Skin topical composition containing epidermal growth factor and fibroblast growth factor | |
| WO2015107237A1 (en) | Cosmetic formulation for topical use, having a dermal, epidermal and anti-wrinkle regeneration capacity | |
| ES2259262B1 (en) | COSMETIC PRODUCT. | |
| JP5602456B2 (en) | Ascorbic acid derivative | |
| KR101917026B1 (en) | Cosmetic composition for skin wrinkle improvement and prevention | |
| ES2292053T3 (en) | PRODUCT FOR SKIN CARE, CONTAINING URSOLIC ACID AND GINKGO EXTRACT. | |
| JP2014210711A (en) | Hyaluronic acid production promoter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20060916 Kind code of ref document: A1 |
|
| FG2A | Definitive protection |
Ref document number: 2259262B1 Country of ref document: ES |